Roche invests 1.2 billion in research and production in Basel
Published: Friday, Nov 17th 2023, 10:40
Zurück zu Live Feed
The pharmaceutical company Roche wants to renew the infrastructure at its Basel site. Over the next two years, 1.2 billion Swiss francs are to be invested in a further research and development building.
The funds will also be used to renew the production facilities for synthetic chemical molecules and for a building for the Institute of Human Biology, as Roche announced on Friday. This investment is a commitment and an important step for the future of the Basel site.
Half a billion will be spent on the research and development building, which will have 13 floors and be 72 meters high. Over half a billion Swiss francs will be spent on the new production building and around 100 million on the Institute of Human Biology.
©Keystone/SDA
German 
English 
French 
Spanish 
Arabic